Skip to content

CDReva

Active Risk: not assessed Private limited companyfounded 2026active for less than a yearForeestelaan 24, 9000 GhentKBO/BCE: BE 1032.971.410

Key points

No accounts filed yet

Signals

Board and ownership

Director
  • 100 sharesdeed of 15-01-2026
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1032971410
Incorporation Founding capital of €1,500, 100 shares · Founded by · appointed as director · published on 15-01-2026 · Gazette deed
First establishment Foreestelaan 24, Ghent
View the timeline

Official details

Source: KBO
Status
Active since 13-01-2026Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.384.528.6309000 Ghent, since 13-01-2026
Financial year end
31 December
Peppol
Reachable since 09-07-2026
Company details

Insights on CDReva

CDReva is less than twelve months old. There is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals.

No annual accounts have been filed with the National Bank.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Key facts about CDReva

What is the company number of CDReva?
The company number of CDReva is 1032.971.410. The VAT number is the same number with BE in front: BE 1032.971.410.
Where is CDReva based?
The registered office is at Foreestelaan 24, 9000 Ghent.Company details
What does CDReva do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of CDReva?
CDReva is a private limited company (BV).
When was CDReva founded?
CDReva was founded on 13-01-2026.
Is CDReva still active?
Yes, CDReva is an active enterprise in the KBO register.
When are the next annual accounts of CDReva due?
CDReva must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.